Cost estimates of diarrhea hospitalizations among children <5 years old in Zimbabwe
- 1 October 2020
- Vol. 38 (43) , 6735-6740
Abstract
No abstract availableKeywords
Funding Information
- World Health Organization
- Centers for Disease Control and Prevention
This publication has 13 references indexed in Scilit:
- Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling studyThe Lancet Global Health, 2019
- Monovalent Rotavirus Vaccine Effectiveness Against Rotavirus Hospitalizations Among Children in ZimbabweClinical Infectious Diseases, 2018
- Effectiveness of Rotavirus Vaccination: A Systematic Review of the First Decade of Global Postlicensure Data, 2006–2016Clinical Infectious Diseases, 2017
- A Preliminary Assessment of Rotavirus Vaccine Effectiveness in ZambiaClinical Infectious Diseases, 2016
- The Economic Burden Attributable to a Child’s Inpatient Admission for Diarrheal Disease in RwandaPLOS ONE, 2016
- Cost-effectiveness of rotavirus vaccination in Kenya and UgandaVaccine, 2015
- 116E rotavirus vaccine development: a successful allianceThe Lancet, 2014
- Rotavirus vaccines. WHO position paper – January 2013.2013
- Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011–2030Vaccine, 2012
- The Economic Burden of Diarrheal Disease in a Tertiary Level Hospital, Gauteng, South AfricaThe Journal of Infectious Diseases, 2010